Portfolio company
Laguna Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops microbial platforms to activate the innate immune system for pharmaceutical partners treating cancer patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Laguna Bio
This company develops engineered microbial therapies that activate the immune system to treat cancer patients.
Kanvas Biosciences
This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.
Exomnis Biotech
This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.
Pragma Bio
This company develops a machine learning platform to discover and manufacture microbiome-derived small molecule medicines for patients with immunological disorders and cancer.
Microbiotica
This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.
Actym Therapeutics
This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
Abacus Bioscience
This company develops active immunotherapies to treat cancer and chronic infections for patients requiring advanced medical treatments.
